<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK55062" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK55062/" /><meta name="ncbi_pagename" content="Chondrodysplasia Punctata 2, X-Linked - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Chondrodysplasia Punctata 2, X-Linked - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Chondrodysplasia Punctata 2, X-Linked" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2011/05/31" /><meta name="citation_author" content="Melissa A Dempsey" /><meta name="citation_author" content="Christopher Tan" /><meta name="citation_author" content="Gail E Herman" /><meta name="citation_pmid" content="21634086" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK55062/" /><meta name="citation_keywords" content="Conradi-Hünermann Syndrome" /><meta name="citation_keywords" content="Happle Syndrome" /><meta name="citation_keywords" content="Conradi-Hunermann Syndrome" /><meta name="citation_keywords" content="Happle Syndrome" /><meta name="citation_keywords" content="3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase" /><meta name="citation_keywords" content="EBP" /><meta name="citation_keywords" content="Chondrodysplasia Punctata 2, X-Linked" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Chondrodysplasia Punctata 2, X-Linked" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Melissa A Dempsey" /><meta name="DC.Contributor" content="Christopher Tan" /><meta name="DC.Contributor" content="Gail E Herman" /><meta name="DC.Date" content="2011/05/31" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK55062/" /><meta name="description" content="The findings in X-linked chondrodysplasia punctata 2 (CDPX2) range from fetal demise with multiple malformations and severe growth retardation to much milder manifestations, including adults with no recognizable physical abnormalities. At least 95% of liveborn individuals with CDPX2 are female with the following findings:" /><meta name="og:title" content="Chondrodysplasia Punctata 2, X-Linked" /><meta name="og:type" content="book" /><meta name="og:description" content="The findings in X-linked chondrodysplasia punctata 2 (CDPX2) range from fetal demise with multiple malformations and severe growth retardation to much milder manifestations, including adults with no recognizable physical abnormalities. At least 95% of liveborn individuals with CDPX2 are female with the following findings:" /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK55062/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/x-dcdp/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK55062/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8C0EB0E0415DE100000000007D002E.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK55062_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK55062_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cdp1-xlr/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/chac/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK55062_"><span class="title" itemprop="name">Chondrodysplasia Punctata 2, X-Linked</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Conradi-H&#x000fc;nermann Syndrome, Happle Syndrome</div><p class="contrib-group"><span itemprop="author">Melissa A Dempsey</span>, MS, CGC, <span itemprop="author">Christopher Tan</span>, MS, CGC, and <span itemprop="author">Gail E Herman</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK55062_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK55062_ai__"><div class="contrib half_rhythm"><span itemprop="author">Melissa A Dempsey</span>, MS, CGC<div class="affiliation small">Certified Genetic Counselor<br />Department of Human Genetics<br />The University of Chicago<br />Chicago, Illinois<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.ogacihcu.dsb@yespmedm" class="oemail">ude.ogacihcu.dsb@yespmedm</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Christopher Tan</span>, MS, CGC<div class="affiliation small">Certified Genetic Counselor<br />Department of Human Genetics<br />The University of Chicago<br />Chicago, Illinois</div></div><div class="contrib half_rhythm"><span itemprop="author">Gail E Herman</span>, MD, PhD<div class="affiliation small">The Research Institute at Nationwide Children's Hospital and Department of Pediatrics<br />The Ohio State University<br />Columbus, Ohio<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.snerdlihcediwnoitan@namreh.liag" class="oemail">gro.snerdlihcediwnoitan@namreh.liag</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">May 31, 2011</span>.</p><p><em>Estimated reading time: 21 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="x-dcdp.Summary" itemprop="description"><h2 id="_x-dcdp_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>The findings in <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> chondrodysplasia punctata 2 (CDPX2) range from fetal demise with multiple malformations and severe growth retardation to much milder manifestations, including adults with no recognizable physical abnormalities. At least 95% of liveborn individuals with CDPX2 are female with the following findings:</p><ul><li class="half_rhythm"><div>Growth deficiency / short stature</div></li><li class="half_rhythm"><div>Distinctive craniofacial appearance</div></li><li class="half_rhythm"><div>Skeletal changes: stippling (chondrodysplasia punctate) on x-rays of the epiphyses of the long bones and vertebrae, the trachea and distal ends of the ribs seen in children prior to completion of normal epiphyseal ossification; rhizomelic (i.e., proximal) shortening of limbs that is often asymmetric; scoliosis</div></li><li class="half_rhythm"><div>Ectodermal changes: linear or blotchy scaling ichthyosis in the newborn that usually resolves in the first months of life leaving linear or whorled atrophic patches involving hair follicles (follicular atrophoderma); coarse hair with scarring alopecia; occasional flattened or split nails; normal teeth</div></li><li class="half_rhythm"><div>Ocular changes: cataracts; microphthalmia and/or microcornea</div></li></ul><p>Intellect is usually normal. Rarely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males have been identified with a <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> that includes: hypotonia; moderate to profound developmental delay; seizures; cerebellar (primarily vermis) hypoplasia and/or Dandy-Walker variant; and agenesis of the corpus callosum.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of CDPX2 rests on the presence of clinical findings consistent with the diagnosis and sterol analysis of plasma, scales from skin lesions, or cultured lymphoblasts or fibroblasts showing increased concentration of 8(9)-cholestenol and 8-dehydrocholesterol. Often a confirmatory <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is identified in <i>EBP</i>, the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which pathogenic variants are known to cause CDPX2.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Treatment is symptomatic and individualized. For females with typical CDPX2 diagnosed in the newborn period, the following are appropriate: orthopedic management of leg length discrepancy; frequent assessment of kyphoscoliosis; cataract extraction and correction of vision; dermatologic management of skin lesions; sun protection; physical, occupational, and speech therapies, if necessary; standard interventions for <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart defects, kidney anomalies, and hearing loss.</p><p><i>Surveillance:</i> Regular follow-up of ophthalmologic abnormalities; regular orthopedic evaluations to monitor kyphoscoliosis, joint problems, and any leg length discrepancy. Routine developmental assessments, hearing evaluations, follow-up with a dermatologist, and monitoring of existing cardiac and/or renal abnormalities.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>CDPX2 is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner with early gestational male lethality. Women with an <i>EBP</i> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have a 50% chance of transmitting the pathogenic variant to each child: <i>EBP</i> pathogenic variants in sons are usually lethal; daughters will have a range of possible phenotypic expression. When the parents are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low but greater than that of the general population. If the pathogenic variant cannot be detected in the DNA extracted from the leukocytes of either parent of the proband, three possible explanations are <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>, <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a>, or a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband. Prenatal diagnosis for pregnancies at increased risk is possible if the family-specific pathogenic variant is known.</p></div></div><div id="x-dcdp.Diagnosis"><h2 id="_x-dcdp_Diagnosis_">Diagnosis</h2><div id="x-dcdp.Clinical_Diagnosis"><h3>Clinical Diagnosis</h3><p>Specific diagnostic criteria for <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> chondrodysplasia punctata (CDPX2) have not been published. The clinical diagnosis rests on the presence of a number of the following features. The clinical findings are highly variable, secondary principally to random <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a>, often with more severe presentations in newborns and infants and milder findings, including short stature only, in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> older children and adults.</p><p><b>Females</b>. Clinical features of CDPX2:</p><ul><li class="half_rhythm"><div><b>Growth deficiency / short stature</b></div></li><li class="half_rhythm"><div><b>Craniofacial appearance</b></div><ul><li class="half_rhythm"><div>Frontal bossing</div></li><li class="half_rhythm"><div>Flat nasal bridge</div></li><li class="half_rhythm"><div>Sparse eyebrows and lashes, often asymmetric</div></li></ul></li><li class="half_rhythm"><div><b>Skeletal</b></div><ul><li class="half_rhythm"><div>Stippling (chondrodysplasia punctata) involving the epiphyses of the long bones and vertebrae, the trachea and distal ends of the ribs seen on x-ray. This is the main criterion for diagnosis of this disorder in infants. The presence of stippling is age dependent and cannot be seen once normal epiphyseal ossification occurs during childhood (see <a class="figpopup" href="/books/NBK55062/figure/x-dcdp.F1/?report=objectonly" target="object" rid-figpopup="figxdcdpF1" rid-ob="figobxdcdpF1">Figure 1</a>).</div></li><li class="half_rhythm"><div>Rhizomelic (i.e., proximal) shortening of limbs that is often asymmetric, but occasionally symmetric</div></li><li class="half_rhythm"><div>Postaxial polydactyly in up to 5% of individuals. Polydactyly appears to be most common in CDPX2 among the various types of chondrodysplasia punctata.</div></li><li class="half_rhythm"><div>Scoliosis, occasionally <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a></div></li></ul></li><li class="half_rhythm"><div><b>Skin, hair, nails</b></div><ul><li class="half_rhythm"><div>Scaling ichthyosis on an erythematous base arranged in a linear or blotchy pattern in the newborn period (following lines of <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a>) that usually resolves in the first months of life. This may be followed by linear or whorled atrophic patches involving hair follicles (follicular atrophoderma) (see <a class="figpopup" href="/books/NBK55062/figure/x-dcdp.F2/?report=objectonly" target="object" rid-figpopup="figxdcdpF2" rid-ob="figobxdcdpF2">Figure 2</a>)</div></li><li class="half_rhythm"><div>Coarse hair with scarring alopecia (see <a class="figpopup" href="/books/NBK55062/figure/x-dcdp.F3/?report=objectonly" target="object" rid-figpopup="figxdcdpF3" rid-ob="figobxdcdpF3">Figure 3</a>)</div></li><li class="half_rhythm"><div>Occasional flattened or split nails with normal teeth</div></li></ul></li><li class="half_rhythm"><div><b>Ocular</b></div><ul><li class="half_rhythm"><div>Cataracts (in ~2/3; 67%), often <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a>, asymmetric and/or sectorial</div></li><li class="half_rhythm"><div>Microphthalmia and/or microcornea</div></li></ul></li><li class="half_rhythm"><div><b>Occasional malformations</b> (&#x0003c;10% of patients)</div><ul><li class="half_rhythm"><div>Sensorineural or conductive hearing loss</div></li><li class="half_rhythm"><div>Cleft palate</div></li><li class="half_rhythm"><div>Congenital heart disease</div></li><li class="half_rhythm"><div>Renal malformations, including hydronephrosis</div></li><li class="half_rhythm"><div>CNS malformations, including Dandy-Walker variant malformation; uncommon in females but usually present in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males, especially posterior fossa defects</div></li></ul></li><li class="half_rhythm"><div><b>Intelligence.</b> Typically normal</div></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figxdcdpF1" co-legend-rid="figlgndxdcdpF1"><a href="/books/NBK55062/figure/x-dcdp.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figxdcdpF1" rid-ob="figobxdcdpF1"><img class="small-thumb" src="/books/NBK55062/bin/x-dcdp-Image001.gif" src-large="/books/NBK55062/bin/x-dcdp-Image001.jpg" alt="Figure 1. " /></a><div class="icnblk_cntnt" id="figlgndxdcdpF1"><h4 id="x-dcdp.F1"><a href="/books/NBK55062/figure/x-dcdp.F1/?report=objectonly" target="object" rid-ob="figobxdcdpF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Radiographs from a female infant with CDPX2 demonstrating epiphyseal stippling (chondrodysplasia punctata) Radiograph originally published in Herman [2000]; reproduced with permission from Elsevier Ltd.</p></div></div><div class="iconblock whole_rhythm clearfix ten_col fig" id="figxdcdpF2" co-legend-rid="figlgndxdcdpF2"><a href="/books/NBK55062/figure/x-dcdp.F2/?report=objectonly" target="object" title="Figure 2" class="img_link icnblk_img figpopup" rid-figpopup="figxdcdpF2" rid-ob="figobxdcdpF2"><img class="small-thumb" src="/books/NBK55062/bin/x-dcdp-Image002.gif" src-large="/books/NBK55062/bin/x-dcdp-Image002.jpg" alt="Figure 2. A." /></a><div class="icnblk_cntnt" id="figlgndxdcdpF2"><h4 id="x-dcdp.F2"><a href="/books/NBK55062/figure/x-dcdp.F2/?report=objectonly" target="object" rid-ob="figobxdcdpF2">Figure 2</a></h4><p class="float-caption no_bottom_margin">A. Typical skin findings of CDPX2 at birth, including scaling and an erythematous eruption that follows lines of X-chromosome inactivation. B. Later hyperpigmentation over the back in a two-month-old female</p></div></div><div class="iconblock whole_rhythm clearfix ten_col fig" id="figxdcdpF3" co-legend-rid="figlgndxdcdpF3"><a href="/books/NBK55062/figure/x-dcdp.F3/?report=objectonly" target="object" title="Figure 3. " class="img_link icnblk_img figpopup" rid-figpopup="figxdcdpF3" rid-ob="figobxdcdpF3"><img class="small-thumb" src="/books/NBK55062/bin/x-dcdp-Image003.gif" src-large="/books/NBK55062/bin/x-dcdp-Image003.jpg" alt="Figure 3. " /></a><div class="icnblk_cntnt" id="figlgndxdcdpF3"><h4 id="x-dcdp.F3"><a href="/books/NBK55062/figure/x-dcdp.F3/?report=objectonly" target="object" rid-ob="figobxdcdpF3">Figure 3. </a></h4><p class="float-caption no_bottom_margin">Scarring, patchy alopecia in a female with CDPX2 Photograph originally published in Herman [2000]; reproduced with permission from Elsevier Ltd.</p></div></div><p><b>Males.</b> Classic features of CDPX2 have been reported in:</p><ul><li class="half_rhythm"><div>A male with a 47,XXY <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a> [<a class="bk_pop" href="#x-dcdp.REF.sutphen.1995.489">Sutphen et al 1995</a>]</div></li><li class="half_rhythm"><div>Males who have not had molecular characterization [<a class="bk_pop" href="#x-dcdp.REF.crovato.1985.1064">Crovato &#x00026; Rebora 1985</a>, <a class="bk_pop" href="#x-dcdp.REF.hochman.1987.565">Hochman &#x00026; Fee 1987</a>, <a class="bk_pop" href="#x-dcdp.REF.de_raeve.1989.167">De Raeve et al 1989</a>, <a class="bk_pop" href="#x-dcdp.REF.tronnier.1992.221">Tronnier et al 1992</a>, <a class="bk_pop" href="#x-dcdp.REF.omobono.1993.117">Omobono &#x00026; Goetsch 1993</a>]</div></li><li class="half_rhythm"><div>Several males with <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> [<a class="bk_pop" href="#x-dcdp.REF.aughton.2003.255">Aughton et al 2003</a>, <a class="bk_pop" href="#x-dcdp.REF.tan.2010">Tan et al 2010</a>]</div></li></ul><p>A total of 11 males with non-mosaic <i>EBP</i> pathogenic variants and/or diagnostic sterol abnormalities have been reported with a distinct, primarily neurologic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#x-dcdp.REF.milunsky.2003.249">Milunsky et al 2003</a>, <a class="bk_pop" href="#x-dcdp.REF.kelley.2005.95">Kelley et al 2005</a>, <a class="bk_pop" href="#x-dcdp.REF.furtado.2010.2838">Furtado et al 2010</a>, <a class="bk_pop" href="#x-dcdp.REF.tan.2010">Tan et al 2010</a>] that includes the following features:</p><ul><li class="half_rhythm"><div><b>Neurologic</b></div><ul><li class="half_rhythm"><div>Hypotonia</div></li><li class="half_rhythm"><div>Moderate to profound developmental delay</div></li><li class="half_rhythm"><div>Seizures</div></li><li class="half_rhythm"><div>Cerebellar (primarily vermis) hypoplasia and/or Dandy Walker variant malformation</div></li><li class="half_rhythm"><div>Agenesis of the corpus callosum</div></li></ul></li><li class="half_rhythm"><div><b>Facial dysmorphisms</b></div><ul><li class="half_rhythm"><div>Hypertelorism</div></li><li class="half_rhythm"><div>Telecanthus</div></li><li class="half_rhythm"><div>High or prominent nasal bridge</div></li><li class="half_rhythm"><div>Low-set ears</div></li><li class="half_rhythm"><div>Micrognathia</div></li><li class="half_rhythm"><div>Large anterior fontanel</div></li></ul></li><li class="half_rhythm"><div><b>Other malformations.</b> Cryptorchidism, hypospadias, pelvocalcyeal obstruction, postaxial polydactyly, 2-3 toe syndactyly, VSD, and ASD</div></li><li class="half_rhythm"><div><b>Features of classic CDPX2.</b> Cataracts and ichthyosis</div></li></ul></div><div id="x-dcdp.Testing"><h3>Testing</h3><p><b>Biochemical testing.</b> Sterol analysis of plasma, scales from skin lesions, or cultured lymphoblasts or fibroblasts is used for diagnosis. Increased concentrations of 8(9)-cholestenol and 8-dehydrocholesterol are essentially diagnostic of CDPX2 [<a class="bk_pop" href="#x-dcdp.REF.kelley.1999.213">Kelley et al 1999</a>] (<a class="figpopup" href="/books/NBK55062/table/x-dcdp.T.concentrations_of_8_9_cholesten/?report=objectonly" target="object" rid-figpopup="figxdcdpTconcentrationsof89cholesten" rid-ob="figobxdcdpTconcentrationsof89cholesten">Table 1</a>).</p><div id="x-dcdp.T.concentrations_of_8_9_cholesten" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Concentrations of 8(9)-Cholestenol and 8-Dehydrocholesterol Observed in CDPX2</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK55062/table/x-dcdp.T.concentrations_of_8_9_cholesten/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__x-dcdp.T.concentrations_of_8_9_cholesten_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_x-dcdp.T.concentrations_of_8_9_cholesten_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Analyte</th><th id="hd_h_x-dcdp.T.concentrations_of_8_9_cholesten_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CDPX2</th><th id="hd_h_x-dcdp.T.concentrations_of_8_9_cholesten_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</th></tr></thead><tbody><tr><td headers="hd_h_x-dcdp.T.concentrations_of_8_9_cholesten_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Plasma 8(9)-cholestenol</td><td headers="hd_h_x-dcdp.T.concentrations_of_8_9_cholesten_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0.18&#x02014;186 &#x003bc;g/mL</td><td headers="hd_h_x-dcdp.T.concentrations_of_8_9_cholesten_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;0.01 &#x003bc;g/mL<br />(for neonates age 1-2 days)</td></tr><tr><td headers="hd_h_x-dcdp.T.concentrations_of_8_9_cholesten_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Plasma 8-dehydrocholesterol</td><td headers="hd_h_x-dcdp.T.concentrations_of_8_9_cholesten_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;0.01&#x02014;138 &#x003bc;g/mL</td><td headers="hd_h_x-dcdp.T.concentrations_of_8_9_cholesten_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;0.01 &#x003bc;g/mL<br />(for neonates age 1-2 days)</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Data from 105 females with presumed CDPX2 [R Kelley, personal communication]</p></div></dd></dl></div></div></div><div id="x-dcdp.Molecular_Genetic_Testing"><h4>Molecular Genetic Testing</h4><p><b>Gene.</b>
<i>EBP</i>, encoding 3&#x003b2;-hydroxysteroid-&#x00394;8, &#x00394;7-isomerase, is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which pathogenic variants are known to cause CDPX2 [<a class="bk_pop" href="#x-dcdp.REF.braverman.1999.291">Braverman et al 1999</a>, <a class="bk_pop" href="#x-dcdp.REF.derry.1999.286">Derry et al 1999</a>].</p><p><b>Sequence analysis</b> of the four <i>EBP</i> coding exons and flanking <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> sequences identifies a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in 85%-95% of females with a clinical diagnosis of CDPX2 and approximately 91% of females with an abnormal sterol profile [<a class="bk_pop" href="#x-dcdp.REF.has.2000.1951">Has et al 2000</a>, <a class="bk_pop" href="#x-dcdp.REF.herman.2002.434">Herman et al 2002</a>]. <a class="bk_pop" href="#x-dcdp.REF.tan.2010">Tan et al [2010]</a> identified a pathogenic variant in four of four males who had abnormal biochemical results.</p><p>Sequence analysis does not identify deletions in females with CDPX2; however, to date no deletions have been identified in females with this disorder.</p><p>Note: The only deletions described are in females with <a href="/books/n/gene/focal-dh/">focal dermal hypoplasia</a> and large deletions that include <i>EBP</i> and <i>PORCN</i>. These females do not have features of CDPX2 [<a class="bk_pop" href="#x-dcdp.REF.porter.2011.6">Porter &#x00026; Herman 2011</a>].</p><div id="x-dcdp.T.molecular_genetic_testing_used" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Chondrodysplasia Punctata 2, X-Linked</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK55062/table/x-dcdp.T.molecular_genetic_testing_used/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__x-dcdp.T.molecular_genetic_testing_used_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_x-dcdp.T.molecular_genetic_testing_used_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_x-dcdp.T.molecular_genetic_testing_used_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_x-dcdp.T.molecular_genetic_testing_used_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_x-dcdp.T.molecular_genetic_testing_used_1_1_1_2" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_x-dcdp.T.molecular_genetic_testing_used_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_x-dcdp.T.molecular_genetic_testing_used_1_1_1_3" style="text-align:left;vertical-align:middle;">Allelic Variants Detected&#x000a0;<sup>2</sup></th><th id="hd_h_x-dcdp.T.molecular_genetic_testing_used_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Variant Detection Frequency by Method&#x000a0;<sup>3</sup></th></tr><tr><th headers="hd_h_x-dcdp.T.molecular_genetic_testing_used_1_1_1_4" id="hd_h_x-dcdp.T.molecular_genetic_testing_used_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Males</th><th headers="hd_h_x-dcdp.T.molecular_genetic_testing_used_1_1_1_4" id="hd_h_x-dcdp.T.molecular_genetic_testing_used_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Heterozygous Females</th></tr></thead><tbody><tr><td headers="hd_h_x-dcdp.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>EBP</i></td><td headers="hd_h_x-dcdp.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup> / scanning for pathogenic variants&#x000a0;<sup>5</sup></td><td headers="hd_h_x-dcdp.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence variants</td><td headers="hd_h_x-dcdp.T.molecular_genetic_testing_used_1_1_1_4 hd_h_x-dcdp.T.molecular_genetic_testing_used_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>6,&#x000a0;7</sup></td><td headers="hd_h_x-dcdp.T.molecular_genetic_testing_used_1_1_1_4 hd_h_x-dcdp.T.molecular_genetic_testing_used_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">90%&#x000a0;<sup>8</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="x-dcdp.TF.2.1"><p class="no_margin">See <a href="/books/NBK55062/#x-dcdp.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="x-dcdp.TF.2.2"><p class="no_margin">See <a href="#x-dcdp.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="x-dcdp.TF.2.3"><p class="no_margin">The ability of the test method used to detect a variant that is present in the indicated <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a></p></div></dd><dt>4. </dt><dd><div id="x-dcdp.TF.2.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="x-dcdp.TF.2.5"><p class="no_margin">Sequence analysis and scanning of the entire <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> for pathogenic variants can have similar detection frequencies; however, detection rates for variant scanning may vary considerably between laboratories based on the specific protocol used.</p></div></dd><dt>6. </dt><dd><div id="x-dcdp.TF.2.6"><p class="no_margin">Lack of amplification by PCRs prior to <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> can suggest a putative <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of one or more exons or the entire <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in a male; confirmation may require additional testing by <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>.</p></div></dd><dt>7. </dt><dd><div id="x-dcdp.TF.2.7"><p class="no_margin">Includes the variant detection frequency using <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>.</p></div></dd><dt>8. </dt><dd><div id="x-dcdp.TF.2.8"><p class="no_margin">Sequence analysis of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA cannot detect <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of one or more exons or the entire <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> female.</p></div></dd></dl></div></div></div></div></div><div id="x-dcdp.Testing_Strategy"><h3>Testing Strategy</h3><p><b>To confirm/establish the diagnosis in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Radiographs showing stippling of the epiphyses of long bones and vertebrae suggest the diagnosis of CDPX2.</div></li><li class="half_rhythm"><div>Biochemical testing revealing an increased concentration of 8(9)-cholestenol in plasma, scales from skin lesions, or cultured lymphoblasts or fibroblasts is diagnostic.</div></li><li class="half_rhythm"><div>Molecular genetic testing using <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> for <i>EBP</i> pathogenic variants confirms the diagnosis, especially when biochemical results are equivocal.</div></li></ul><p><b>Testing for at-risk relatives</b> requires prior identification of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family.</p><p>Note: (1) Females are heterozygotes for this <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> male lethal disorder. (2) Identification of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in females requires either (a) prior identification of the pathogenic variant in the family or, (b) if an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> relative is not available for testing, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> first by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, and then, if no pathogenic variant is identified, by methods to detect gross structural abnormalities<i>.</i></p><p><b>Prenatal diagnosis and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> (PGD)</b> for at-risk pregnancies require prior identification of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family. Note: Prenatal diagnosis by measurement of 8(9)-cholestenol and 8-dehydrocholesterol is also possible; the risk for a false negative result has not been determined.</p></div></div><div id="x-dcdp.Clinical_Characteristics"><h2 id="_x-dcdp_Clinical_Characteristics_">Clinical Characteristics</h2><div id="x-dcdp.Clinical_Description"><h3>Clinical Description</h3><p>At least 95% of individuals with <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> chondrodysplasia punctata 2 (CDPX2) are female. The clinical phenotypes in <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females are highly variable and depend on the pattern of <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a> in relevant tissues (i.e., percentage of wild type versus mutated active X chromosomes), as well as the exact <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, and other possible modifying factors. Phenotypes range from fetal demise with multiple malformations and severe growth retardation to much milder manifestations, including adults with no recognizable physical abnormalities. Severity in females varies greatly within families and among individuals with the same pathogenic variant, as would be expected for a pathogenic process determined, in part, by the random process of X-chromosome inactivation.</p><p>Although CDPX2 was for many years presumed to be lethal in males, a small number of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males have been reported [<a class="bk_pop" href="#x-dcdp.REF.crovato.1985.1064">Crovato &#x00026; Rebora 1985</a>, <a class="bk_pop" href="#x-dcdp.REF.hochman.1987.565">Hochman &#x00026; Fee 1987</a>, <a class="bk_pop" href="#x-dcdp.REF.de_raeve.1989.167">De Raeve et al 1989</a>, <a class="bk_pop" href="#x-dcdp.REF.tronnier.1992.221">Tronnier et al 1992</a>, <a class="bk_pop" href="#x-dcdp.REF.omobono.1993.117">Omobono &#x00026; Goetsch 1993</a>, <a class="bk_pop" href="#x-dcdp.REF.sutphen.1995.489">Sutphen et al 1995</a>, <a class="bk_pop" href="#x-dcdp.REF.aughton.2003.255">Aughton et al 2003</a>]. <a class="bk_pop" href="#x-dcdp.REF.sutphen.1995.489">Sutphen et al [1995]</a> describe a male with CDPX2 and a 47,XXY <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a>. <a class="bk_pop" href="#x-dcdp.REF.aughton.2003.255">Aughton et al [2003]</a> describe a male who is mosaic for the variant <a class="figpopup" href="/books/NBK55062/table/x-dcdp.T.selected_ebp_variants/?report=objectonly" target="object" rid-figpopup="figxdcdpTselectedebpvariants" rid-ob="figobxdcdpTselectedebpvariants">c.238G&#x0003e;A</a> (p.Glu80Lys), which has been reported in affected females. <a class="bk_pop" href="#x-dcdp.REF.tan.2010">Tan et al [2010]</a> describe three males with novel <i>EBP</i> variants identified in the mosaic state. The clinical characteristics of males with mosaic <i>EBP</i> pathogenic variants are well within the marked variability described in affected females.</p><p>In addition, <a class="bk_pop" href="#x-dcdp.REF.milunsky.2003.249">Milunsky et al [2003]</a> and <a class="bk_pop" href="#x-dcdp.REF.furtado.2010.2838">Furtado et al [2010]</a> reported a neurologic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, distinct from that found in CDPX2, in males with a <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> <i>EBP</i> pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant. Of the 11 hemizygous or presumed hemizygous males with CDPX2 known to the authors, all have had moderate to severe developmental delay and almost all have clinically important CNS malformations, most notable Dandy-Walker variant, agenesis of the corpus callosum, and major gyral abnormalities. Other unique findings include facial dysmorphisms, skeletal findings (2-3 toe syndactyly, postaxial polydactyly) and urogenital findings (cryptorchidism, hypospadias). Many hemizygous males have chronic ichthyosis, but, as would be predicted, not in patchy distributions.</p><p><b>Growth deficiency / short stature.</b> Individuals with CDPX2 have short stature. Reported heights range from the10th-25th percentile to six standard deviations below the mean.</p><p><b>Craniofacial appearance.</b> The face and head are often asymmetric. Most individuals with CDPX2 have a flattened nasal bridge and frontal bossing. Other distinctive features include downslanting palpebral fissures, ocular hypertelorism, low-set ears, and high-arched palate [<a class="bk_pop" href="#x-dcdp.REF.happle.1979.65">Happle 1979</a>, <a class="bk_pop" href="#x-dcdp.REF.herman.2000.357">Herman 2000</a>].</p><p><b>Skeletal.</b> Stippling (chondrodysplasia punctata) involving the epiphyses of the long bones and vertebrae and tracheal cartilage and otherwise widespread is seen on x-rays in almost 100% of symptomatic infants; however, this could reflect bias of ascertainment.</p><p>Approximately 90% of individuals have asymmetric shortening of limbs (occasionally symmetric), involving mostly the femur, humerus, and other tubular bones [<a class="bk_pop" href="#x-dcdp.REF.happle.1979.65">Happle 1979</a>].</p><p>Moderate to severe kyphoscoliosis is common and can present in infancy or early childhood. Spinal deformities can progress rapidly; in addition, progressive deformity following surgical vertebral fusion is common [<a class="bk_pop" href="#x-dcdp.REF.mason.2002.1995">Mason et al 2002</a>]. Contractures, other joint abnormalities, dislocated patella, and postaxial polydactyly have also been reported [<a class="bk_pop" href="#x-dcdp.REF.happle.1979.65">Happle 1979</a>, <a class="bk_pop" href="#x-dcdp.REF.herman.2000.357">Herman 2000</a>].</p><p><b>Skin, hair, and nails.</b> Scaling ichthyosis, present in newborns in a linear or blotchy pattern, usually resolves in the first weeks or months of life. This erythematous eruption seen at birth often follows the lines of <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a> (i.e., the lines of Blaschko) and has a feather-like edge, but total scaling erythroderma also occurs. As this rash fades, it leaves in a linear or whorled pattern areas of atrophoderma predominantly near hair follicles where scales had been located. Some individuals also have ichthyosis and/or pigmentary abnormalities that persist into childhood.</p><p>Hair findings include scarring alopecia in patches, sparse eyelashes and eyebrows, and coarse, lusterless hair.</p><p>Minor nail findings include flattening and splitting of the nail plates [<a class="bk_pop" href="#x-dcdp.REF.happle.1979.65">Happle 1979</a>, <a class="bk_pop" href="#x-dcdp.REF.herman.2000.357">Herman 2000</a>, <a class="bk_pop" href="#x-dcdp.REF.hoang.2004.53">Hoang et al 2004</a>].</p><p><b>Ocular.</b> Approximately two thirds of individuals have cataracts at birth or develop them early in life. Cataracts are usually unilateral, asymmetric, and/or sectorial [<a class="bk_pop" href="#x-dcdp.REF.happle.1979.65">Happle 1979</a>, <a class="bk_pop" href="#x-dcdp.REF.happle.1981.64">Happle 1981</a>, <a class="bk_pop" href="#x-dcdp.REF.herman.2002.434">Herman et al 2002</a>]. Other eye findings include microphthalmia and/or microcornea.</p><p><b>Neurologic.</b> Intelligence is typically normal in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals unless a CNS malformation is present. Other (rarely seen) neurologic findings can include microcephaly, seizures, and tethered cord [<a class="bk_pop" href="#x-dcdp.REF.herman.2002.434">Herman et al 2002</a>].</p><p><b>Ear anomalies and hearing.</b> Rarely, dysplastic auricles and sensorineural hearing loss have been reported in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#x-dcdp.REF.happle.1979.65">Happle 1979</a>, <a class="bk_pop" href="#x-dcdp.REF.herman.2002.434">Herman et al 2002</a>].</p><p><b>Other findings.</b> Individuals with CDPX2 may also have bilateral or unilateral clubfoot and renal or cardiac malformations [<a class="bk_pop" href="#x-dcdp.REF.happle.1979.65">Happle 1979</a>, <a class="bk_pop" href="#x-dcdp.REF.herman.2002.434">Herman et al 2002</a>]. Hydronephrosis has been seen in several <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> girls.</p><p><b>Mortality.</b> Typically life expectancy is normal in individuals with CDPX2 as long as severe scoliosis has not compromised heart and lung function.</p></div><div id="x-dcdp.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>There are no confirmed <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>/<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlations.</p><p><a class="bk_pop" href="#x-dcdp.REF.ikegawa.2000.300">Ikegawa et al [2000]</a> suggested that <i>EBP</i> pathogenic variants resulting in truncated proteins cause typical CDPX2 manifestations including skeletal, skin, and ocular findings, while pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants may result in a milder <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> lacking some of these classic findings. However, other studies have shown no such correlation [<a class="bk_pop" href="#x-dcdp.REF.braverman.1999.291">Braverman et al 1999</a>, <a class="bk_pop" href="#x-dcdp.REF.herman.2002.434">Herman et al 2002</a>].</p><p>The wide variation in <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is most likely due to <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a> patterns [<a class="bk_pop" href="#x-dcdp.REF.shirahama.2003.78">Shirahama et al 2003</a>], making <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> difficult to study. Although a genotype-phenotype correlation is more likely to be detected among <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> males with a <a class="def" href="/books/n/gene/glossary/def-item/hypomorphic/">hypomorphic</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, few <i>EBP</i>-deficient males are known at this time.</p></div><div id="x-dcdp.Penetrance"><h3>Penetrance</h3><p>No unaffected males or females with an <i>EBP</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have been reported; thus, <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> appears to be complete. Some women have been so mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> that they were identified only after having had a child with more severe features in whom CDXP2 was diagnosed. Although these adult women have subtle findings, their findings are sufficient to consider them affected.</p></div><div id="x-dcdp.Anticipation"><h3>Anticipation</h3><p>Although increasing severity of <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in successive generations has been observed in a few instances, this is more likely secondary to <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> or variation in <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a> than true genetic <a class="def" href="/books/n/gene/glossary/def-item/anticipation/">anticipation</a> [<a class="bk_pop" href="#x-dcdp.REF.has.2000.1951">Has et al 2000</a>, <a class="bk_pop" href="#x-dcdp.REF.herman.2002.434">Herman et al 2002</a>, <a class="bk_pop" href="#x-dcdp.REF.shirahama.2003.78">Shirahama et al 2003</a>].</p></div><div id="x-dcdp.Nomenclature"><h3>Nomenclature</h3><p><a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> chondrodysplasia punctata (CDPX2) has also been referred to as:</p><ul><li class="half_rhythm"><div>Conradi-H&#x000fc;nermann syndrome, named after <a class="bk_pop" href="#x-dcdp.REF.conradi.1914.86">Conradi [1914]</a> and <a class="bk_pop" href="#x-dcdp.REF.h_nermann.1931.1">H&#x000fc;nermann [1931]</a> who described the first persons with this disorder;</div></li><li class="half_rhythm"><div>Happle syndrome, named after Rudolph Happle [<a class="bk_pop" href="#x-dcdp.REF.happle.1979.65">Happle 1979</a>, <a class="bk_pop" href="#x-dcdp.REF.happle.1981.64">Happle 1981</a>] who contributed greatly to characterization of the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> and delineation of the <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a> and possible etiologies of the syndrome [<a class="bk_pop" href="#x-dcdp.REF.traupe.1999.324">Traupe 1999</a>, <a class="bk_pop" href="#x-dcdp.REF.sheffield.2001.283">Sheffield 2001</a>];</div></li><li class="half_rhythm"><div>Conradi-H&#x000fc;nermann-Happle syndrome, which recognizes all three individuals who helped to define this disorder</div></li></ul></div><div id="x-dcdp.Prevalence"><h3>Prevalence</h3><p>Based on rates of biochemical diagnosis of CDPX2 compared to <a href="/books/n/gene/slo/">Smith-Lemli-Opitz syndrome</a> (incidence of 1 in 75-100,000 births) in one laboratory, the recognized incidence of CDPX2 is no more than one fifth the rate for Smith-Lemli-Opitz syndrome, or no greater than approximately one in 400,000 births. This number may be an underestimate because of individuals with milder features who may not be accurately diagnosed.</p></div></div><div id="x-dcdp.Genetically_Related_Allelic_Disor"><h2 id="_x-dcdp_Genetically_Related_Allelic_Disor_">Genetically Related (Allelic) Disorders</h2><p>As noted in <a href="#x-dcdp.Clinical_Diagnosis">Clinical Diagnosis</a>, rare males with a 46,XY <a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a> and a non-mosaic, presumably <a class="def" href="/books/n/gene/glossary/def-item/hypomorphic/">hypomorphic</a>, <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>EBP</i> have been reported with a <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> distinct from CDPX2.</p><p><a class="bk_pop" href="#x-dcdp.REF.grange.2000.328">Grange et al [2000]</a> reported an <i>EBP</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in a female with phenotypic features more suggestive of CHILD syndrome (see <a href="/books/n/gene/nsdhl-dis/"><i>NSDHL</i>-Related Disorders</a>), although <a class="bk_pop" href="#x-dcdp.REF.happle.2000.341">Happle et al [2000]</a> have argued that the skin findings in this case more accurately represent CDPX2 with extensive asymmetry.</p></div><div id="x-dcdp.Differential_Diagnosis"><h2 id="_x-dcdp_Differential_Diagnosis_">Differential Diagnosis</h2><p>Several disorders described below demonstrate features similar to those of chondrodysplasia punctata and/or manifest stippling on radiographs and various combinations of limb asymmetry, short stature, intellectual disability, cataracts, and skin changes. The key radiologic finding of chondrodysplasia punctata (CDP) occurs in various metabolic disorders, skeletal dysplasias, <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> abnormalities, and teratogen exposures.</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Rhizomelic chondrodysplasia punctata (RCDP), type 1, 2, or 3.</b> This group of disorders shares with CDPX2 the features of rhizomelic shortening of the limbs, punctate calcifications in cartilage with epiphyseal and metaphyseal abnormalities (chondrodysplasia punctata), vertebral abnormalities (notching but not commonly CDP), and cataracts that are usually present at birth or appear in the first few months of life. Birth size is often in the lower range of normal, but postnatal growth deficiency is profound, intellectual disability severe, and seizures common. The skeletal findings and cataracts are more symmetric than in CDPX2. Most children with RCDP do not survive the first decade of life, and a substantial proportion die in the neonatal period. All types of RCDP are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner; type 1 is the most common. (See <a href="/books/n/gene/rcdp/">Rhizomelic Chondrodysplasia Punctata Type 1</a>.)</div><div class="half_rhythm">Biochemical diagnosis is based on a deficiency of plasmalogens in erythrocyte membranes and confirmed by demonstration of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in one of three genes: <i>PEX7</i>, encoding the PTS2 peroxisomal protein import system (RCDP type 1); <i>GNPAT,</i> encoding dihydroxyacetonephosphate acyltransferase (RCDP type 2); or <i>AGPS</i>, encoding alkyldihydroacetonephosphate synthase (RCDP type 3).</div></li><li class="half_rhythm"><div class="half_rhythm"><a href="/books/n/gene/cdp1-xlr/"><b>X-linked recessive chondrodysplasia punctata</b></a><b>, or brachytelephalangic type (CDPX1)</b> is caused by defects in arylsulfatase E (ARSE), a vitamin K-dependent enzyme. Affected males have hypoplasia of the distal phalanges without limb shortening or cataracts. The diagnosis is confirmed by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>. Contiguous <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions involving <i>ARSL</i> and other genes in this region result in more complex phenotypes, including, variously, additional findings of ichthyosis, anosmia, hypogonadism, short stature, and corneal opacities.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Chondrodysplasia punctata, tibia-metacarpal</b> and <b>humero-metacarpal types</b> are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. The <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> defect(s) are unknown. Affected individuals have short limbs due primarily to shortening of the metacarpals and tibiae/humeri. No skin or eye changes are present, and prognosis is good.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Warfarin embryopathy and other vitamin K deficiencies</b> (including vitamin K epoxide reductase deficiency) are phenotypically similar to CDPX1 with especially severe hypoplasia of the nasal bone ("Binder anomaly").</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Maternal systemic lupus erythematosus (SLE)</b> can cause CDP with rhizomelic limb shortening.</div></li></ul><p>The following syndrome demonstrates other overlapping features of CDPX2 and may need to be considered.</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>CHILD (<a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> hemidysplasia, ichthyosis, and limb defects) syndrome</b> is also <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a>, apparently male-lethal, and associated with skin and limb abnormalities (see <a href="/books/n/gene/nsdhl-dis/"><i>NSDHL</i>-Related Disorders</a>). The skin lesions typically present at birth and often persist, but can develop at any age, often at a site of skin damage. The skin lesions histologically are ichthyosiform nevi and, more often than not, do not conform to lines of Blaschko [<a class="bk_pop" href="#x-dcdp.REF.happle.1981.64">Happle 1981</a>, <a class="bk_pop" href="#x-dcdp.REF.herman.2000.357">Herman 2000</a>, <a class="bk_pop" href="#x-dcdp.REF.bornholdt.2005.e17">Bornholdt et al 2005</a>]. Ipsilateral limb defects, often reduction in type, are found with epiphyseal stippling noted in infancy. Alopecia and internal malformations may occur, and occasional skin lesions on the "unaffected" side or even symmetric lesions have been reported. Cataracts have not been reported.</div><div class="half_rhythm">CHILD syndrome is caused by mutation of <i>NSDHL</i>, which encodes a cholesterol biosynthetic 4-methylsterol dehydrogenase [<a class="bk_pop" href="#x-dcdp.REF.k_nig.2000.339">K&#x000f6;nig et al 2000</a>]. The enzyme, part of a 4-methylsterol demethylase complex, occurs one step proximal to the <i>EBP</i> sterol isomerase.</div><div class="half_rhythm">Both CHILD syndrome and CDPX2 cause pathognomonic abnormalities in plasma or tissue sterol levels. Individuals with CHILD syndrome have increased levels of 4-methyl- and carboxysterols in cultured lymphoblasts, but only occasionally in plasma, whereas those with CDPX2 have increased levels of 8(9)-cholestenol and 8-dehydrocholeterol. In cultured lymphoblasts, both disorders manifest a paradoxical increase in the distal sterol metabolite lathosterol, including <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> males with an <i>EBP</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The embryologic cause of the CHILD <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, common in NSDHL deficiency and rare in EBP deficiency, is unknown. Interestingly, fibroblasts cultured from normal skin from both the hemidysplastic and normal sides of the body can manifest the classic, abnormal sterol profile.</div></li></ul></div><div id="x-dcdp.Management"><h2 id="_x-dcdp_Management_">Management</h2><p>No published guidelines exist to establish the extent of disease or proper management in an individual with <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> chondrodysplasia punctata 2 (CDPX2). The following recommendations are based on current literature and the authors' experience.</p><div id="x-dcdp.Evaluations_Following_Initial_Dia"><h3>Evaluations Following Initial Diagnosis</h3><p>The following are appropriate:</p><ul><li class="half_rhythm"><div>Physical examination with attention to growth parameters, skin, hair, and skeleton, as well as possible internal malformations (CNS, cardiac, renal)</div></li><li class="half_rhythm"><div>Full skeletal survey and orthopedic evaluation to assess limb length differences, kyphoscoliosis, and other skeletal abnormalities, including polydactyly</div></li><li class="half_rhythm"><div>Pulmonary evaluation, if scoliosis compromises respiratory function</div></li><li class="half_rhythm"><div>Dermatologic evaluation to exclude other causes of the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a></div></li><li class="half_rhythm"><div>Ophthalmologic evaluation for <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> cataracts and other eye abnormalities</div></li><li class="half_rhythm"><div>Developmental assessment (after the newborn period)</div></li><li class="half_rhythm"><div>Echocardiogram for possible <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart defect at the time of diagnosis</div></li><li class="half_rhythm"><div>Renal ultrasound examination for possible kidney anomalies</div></li><li class="half_rhythm"><div>Hearing evaluation to detect hearing loss</div></li></ul></div><div id="x-dcdp.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Treatment is symptomatic and should be tailored to each patient. For females with typical CDPX2 diagnosed in the newborn period:</p><ul><li class="half_rhythm"><div>Orthopedic management of leg length discrepancy; surgical correction of polydactyly; frequent assessment of kyphoscoliosis, which can progress rapidly at any age</div></li><li class="half_rhythm"><div>Cataract extraction and correction of vision</div></li><li class="half_rhythm"><div>Dermatologic management of skin lesions</div></li><li class="half_rhythm"><div>Physical, occupational, and speech therapies, if necessary</div></li><li class="half_rhythm"><div>Standard interventions for <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart defects, kidney anomalies, and hearing loss</div></li></ul></div><div id="x-dcdp.Surveillance"><h3>Surveillance</h3><p>Appropriate surveillance includes:</p><ul><li class="half_rhythm"><div>Regular follow-up of ophthalmologic abnormalities</div></li><li class="half_rhythm"><div>Regular orthopedic evaluations to monitor kyphoscoliosis or joint problems and assess linear growth and any leg length discrepancy</div></li><li class="half_rhythm"><div>Ongoing developmental assessments</div></li><li class="half_rhythm"><div>Ongoing follow up with dermatologist</div></li><li class="half_rhythm"><div>Routine monitoring of any existing cardiac and/or renal abnormalities</div></li><li class="half_rhythm"><div>Regular hearing evaluations</div></li></ul></div><div id="x-dcdp.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#x-dcdp.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="x-dcdp.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://www.ClinicalTrials.gov" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="x-dcdp.Genetic_Counseling"><h2 id="_x-dcdp_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="x-dcdp.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> chondrodysplasia punctata 2 (CDPX2) is inherited in an X-linked manner with male lethality.</p></div><div id="x-dcdp.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is a female and if <a class="def" href="/books/n/gene/glossary/def-item/pedigree/">pedigree</a> analysis reveals that she is the only <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, it is reasonable to offer <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> to both of her parents to determine risks to family members.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>&#x02019;s father is asymptomatic, it is possible, but not likely, that he has the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in some cells in his body (<a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a>). If her father is asymptomatic and does not have somatic mosaicism for the altered <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>, the possible genetic explanations for the origin of the pathogenic variant found in the proband are the same as for a male proband with a negative family history.</div></li></ul><p><b>Parents of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>CDPX2 is presumed lethal in males, though a small number of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males have been reported.</div></li><li class="half_rhythm"><div>The father of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male will not have the disease nor will he be a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>In a family with more that one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual, the mother of an affected male is an <a class="def" href="/books/n/gene/glossary/def-item/obligate-carrier/">obligate carrier</a>.</div></li></ul><p>If <a class="def" href="/books/n/gene/glossary/def-item/pedigree/">pedigree</a> analysis reveals that the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is the only <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, four possible genetic explanations exist:</p><ul><li class="half_rhythm"><div>The <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>EBP</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. In this instance, the proband&#x02019;s mother does not have a pathogenic variant and the only other family members at risk are the offspring of the proband. <i>De novo</i>
<i>EBP</i> pathogenic variants have been reported.</div></li><li class="half_rhythm"><div>The mother has inherited the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from her mother.</div></li><li class="half_rhythm"><div>The <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>&#x02019;s mother has a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. One of three types of <i>de novo</i> variants may be present in the mother:</div><dl class="temp-labeled-list"><dt>a.</dt><dd><p class="no_top_margin">A <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>EBP</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> that was present at the time of her conception, is present in every cell of her body, and is detectable in her leukocytes; however, because of variability in <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a> patterns, the mother may have very subtle to no features of CDPX2;</p></dd><dt>b.</dt><dd><p class="no_top_margin">A somatic <i>EBP</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> that occurred in one cell after conception that populated some tissues in her body including her <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a>. This may cause very subtle to no features of CDPX2 and has been reported in individuals with CDPX2 [<a class="bk_pop" href="#x-dcdp.REF.has.2000.1951">Has et al 2000</a>];</p></dd><dt>c.</dt><dd><p class="no_top_margin">An <i>EBP</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> that is present only in her ovaries (termed "<a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>") in which some germ cells have the variant and some do not, and in which the variant is often not detectable in DNA extracted from leukocytes. Germline mosaicism has been reported in families with CDPX2 [<a class="bk_pop" href="#x-dcdp.REF.has.2000.1951">Has et al 2000</a>].</p></dd></dl></li></ul><p>In all above instances (a, b, and c), each of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s mother's offspring is at risk of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; none of the proband's mother's sibs, however, is at risk of inheriting it.</p><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of a proband depends on the genetic status of the parents.</p><ul><li class="half_rhythm"><div>If a parent has a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the chance in each pregnancy of transmitting the pathogenic variant is 50%.</div></li><li class="half_rhythm"><div>When the parents are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low but greater than that of the general population.</div><ul><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in the DNA extracted from the leukocytes of either parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>, three possible explanations are (a) <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> or (b) <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> (including the germline) in a parent or (c) a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband.</div></li><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the probability of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent of the proband. Germline mosaicism is rare in CDPX2, but it has been reported [<a class="bk_pop" href="#x-dcdp.REF.has.2000.1951">Has et al 2000</a>].</div></li></ul></li></ul><p><b>Offspring of a female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Women with an <i>EBP</i> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have a 50% chance of transmitting the pathogenic variant to each child: <i>EBP</i> pathogenic variants in sons are usually lethal; daughters will have a range of possible phenotypic expression.</p><p><b>Offspring of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Affected males would transmit the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> to all of their daughters and none of their sons; however, to the authors' knowledge, no <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males have been reported to reproduce.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> If a parent of the proband also has a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his/her female family members may be at risk of being carriers (asymptomatic or symptomatic) and his/her family members may be at risk of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> depending on their genetic relationship to the proband.</p></div><div id="x-dcdp.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, have the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, or are at risk of having the pathogenic variant.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="x-dcdp.Prenatal_Testing_and_Preimplantat"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="x-dcdp.Resources"><h2 id="_x-dcdp_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Foundation for Ichthyosis and Related Skin Types, Inc. (FIRST)</b></div><div>2616 North Broad Street</div><div>Colmar PA 18915</div><div><b>Phone:</b> 215-997-9400</div><div><b>Email:</b> info@firstskinfoundation.org</div><div><a href="http://www.firstskinfoundation.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.firstskinfoundation.org</a></div></li><li class="half_rhythm"><div><b>Little People of America, Inc. (LPA)</b></div><div>250 El Camino Real</div><div>Suite 201</div><div>Tustin CA 92780</div><div><b>Phone:</b> 888-572-2001 (toll-free); 714-368-3689</div><div><b>Fax:</b> 714-368-3367</div><div><b>Email:</b> info@lpaonline.org</div><div><a href="http://www.lpaonline.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.lpaonline.org</a></div></li><li class="half_rhythm"><div><b>MAGIC Foundation</b></div><div>4200 Cantera Drive #106</div><div>Warrenville IL 60555</div><div><b>Phone:</b> 800-362-4423 (Toll-free Parent Help Line); 630-836-8200</div><div><b>Fax:</b> 630-836-8181</div><div><b>Email:</b> contactus@magicfoundation.org</div><div><a href="http://www.magicfoundation.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.magicfoundation.org</a></div></li><li class="half_rhythm"><div><b>International Skeletal Dysplasia Registry</b></div><div>UCLA</div><div>615 Charles E. Young Drive</div><div>South Room 410</div><div>Los Angeles CA 90095-7358</div><div><b>Phone:</b> 310-825-8998</div><div><b>Fax:</b> 310-206-5266</div><div><b>Email:</b> Salon@mednet.ucla.edu</div><div><a href="https://www.uclahealth.org/ortho/isdr" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">International Skeletal Dysplasia Registry</a></div></li></ul></div><div id="x-dcdp.Molecular_Genetics"><h2 id="_x-dcdp_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="x-dcdp.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Chondrodysplasia Punctata 2, X-Linked: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK55062/table/x-dcdp.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__x-dcdp.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_x-dcdp.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_x-dcdp.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_x-dcdp.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_x-dcdp.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_x-dcdp.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_x-dcdp.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_x-dcdp.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/10682" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>EBP</i></a></td><td headers="hd_b_x-dcdp.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=10682" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Xp11<wbr style="display:inline-block"></wbr>​.23</a></td><td headers="hd_b_x-dcdp.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q15125" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase</a></td><td headers="hd_b_x-dcdp.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/EBP" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EBP database</a></td><td headers="hd_b_x-dcdp.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=EBP" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EBP</a></td><td headers="hd_b_x-dcdp.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=EBP[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EBP</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="x-dcdp.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="x-dcdp.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Chondrodysplasia Punctata 2, X-Linked (<a href="/omim/300205,302960" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK55062/table/x-dcdp.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__x-dcdp.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300205" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300205</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EMOPAMIL-BINDING PROTEIN; EBP</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/302960" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">302960</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2</td></tr></tbody></table></div></div><div id="x-dcdp.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p><a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> chondrodysplasia punctata 2 (CDPX2) is caused by a deficiency of 3&#x003b2;-hydroxysteroid-&#x00394;8, &#x00394;7-isomerase or "sterol-&#x00394;8-isomerase," which converts 8(9)-cholestenol to lathosterol during cholesterol biosynthesis. Lathosterol is then converted to 7-dehydrocholesterol, which is a primary precursor for synthesizing both cholesterol and vitamin A [<a class="bk_pop" href="#x-dcdp.REF.kelley.1999.213">Kelley et al 1999</a>]. Human sterol-&#x00394;8-isomerase is encoded by the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <i>EBP</i> (<i>e</i>mapomil-<i>b</i>inding <i>p</i>rotein) [<a class="bk_pop" href="#x-dcdp.REF.braverman.1999.291">Braverman et al 1999</a>, <a class="bk_pop" href="#x-dcdp.REF.derry.1999.286">Derry et al 1999</a>]. <i>EBP</i> is presumably subjected to <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a>, which is responsible for the variability in phenotypes among females.</p><p><b>Gene structure.</b>
<i>EBP</i> comprises approximately 7.0 kb of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA and consists of five exons, of which only four are coding exons. It encodes a 230-aa protein, which is thought to be an integral endoplasmic reticulum membrane protein that contains four potential transmembrane domains and a potential site for cAMP-dependent protein kinase phosphorylation. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK55062/#x-dcdp.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Benign variants.</b> The synonymous c.15G&#x0003e;T (p.Ala5Ala) rs3048 <a class="def" href="/books/n/gene/glossary/def-item/benign-variant/">benign variant</a> in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 2 is the only non-pathogenic sequence change reported with a high frequency in <i>EBP</i>. This variant has a frequency of 39%, 21%, 48%, and 46% in the white, African, Japanese, and Chinese populations, respectively.</p><p><b>Pathogenic variants.</b> More than 55 <i>EBP</i> variants have been reported in individuals with CDPX2. Variants have been found in all of the coding exons of <i>EBP</i>, with a majority found in exons 2 and 4. Small deletions and insertions, <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants, frameshifts, and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> and <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants have been reported. Functional studies have confirmed the pathogenesis of a small number of missense variants [<a class="bk_pop" href="#x-dcdp.REF.braverman.1999.291">Braverman et al 1999</a>]. A number of variants appear to be recurrent, and variants commonly occur at CpG dinucleotides, representing likely "hot spots" [<a class="bk_pop" href="#x-dcdp.REF.herman.2002.434">Herman et al 2002</a>].</p><div id="x-dcdp.T.selected_ebp_variants" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Selected <i>EBP</i> Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK55062/table/x-dcdp.T.selected_ebp_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__x-dcdp.T.selected_ebp_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_x-dcdp.T.selected_ebp_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant Classification</th><th id="hd_h_x-dcdp.T.selected_ebp_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_x-dcdp.T.selected_ebp_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th></tr></thead><tbody><tr><td headers="hd_h_x-dcdp.T.selected_ebp_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Benign</b></td><td headers="hd_h_x-dcdp.T.selected_ebp_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.15G&#x0003e;T&#x000a0;<sup>1</sup></td><td headers="hd_h_x-dcdp.T.selected_ebp_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala5Ala</td></tr><tr><td headers="hd_h_x-dcdp.T.selected_ebp_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Pathogenic</b></td><td headers="hd_h_x-dcdp.T.selected_ebp_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.238G&#x0003e;A</td><td headers="hd_h_x-dcdp.T.selected_ebp_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu80Lys</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="x-dcdp.TF.3.1"><p class="no_margin"><a href="/projects/SNP/snp_ref.cgi?rs=3048" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www<wbr style="display:inline-block"></wbr>​.ncbi.nlm.nih.gov/projects/SNP</a></p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>EBP</i> encodes 3&#x003b2;-hydroxysteroid-&#x00394;8, &#x00394;7-isomerase, an enzyme important in cholesterol biosynthesis. This enzyme converts 8(9)-cholestenol to lathosterol, which is then converted to 7-dehydrocholesterol, a primary precursor for synthesizing cholesterol and vitamin A [<a class="bk_pop" href="#x-dcdp.REF.kelley.1999.213">Kelley et al 1999</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Decreased function of the 3&#x003b2;-hydroxysteroid-&#x00394;8, &#x00394;7-isomerase causes the accumulation of sterol intermediates above the enzymatic block, as well as reduced cellular cholesterol. Plasma cholesterol levels in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females are usually normal. The exact mechanism(s) producing the clinical features seen in females with CDPX2 are not known.</p></div></div><div id="x-dcdp.References"><h2 id="_x-dcdp_References_">References</h2><div id="x-dcdp.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="x-dcdp.REF.aughton.2003.255">Aughton DJ, Kelley RI, Metzenberg A, Pureza V, Pauli RM. X-linked dominant chondrodysplasia punctata (CDPX2) caused by single gene mosaicism in a male. <span><span class="ref-journal">Am J Med Genet A. </span>2003;<span class="ref-vol">116A</span>:255–60.</span> [<a href="/pubmed/12503102" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12503102</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-dcdp.REF.bornholdt.2005.e17">Bornholdt D, K&#x000f6;nig A, Happle R, Leveleki L, Bittar M, Danarti R, Vahlquist A, Tilgen W, Reinhold U, Poiares Baptista A, Grosshans E, Vabres P, Niiyama S, Sasaoka K, Tanaka T, Meiss AL, Treadwell PA, Lambert D, Camacho F, Grzeschik KH. Mutational spectrum of NSDHL in CHILD syndrome. <span><span class="ref-journal">J Med Genet. </span>2005;<span class="ref-vol">42</span>:e17.</span> [<a href="/pmc/articles/PMC1735983/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735983</span></a>] [<a href="/pubmed/15689440" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15689440</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-dcdp.REF.braverman.1999.291">Braverman N, Lin P, Moebius FF, Obie C, Moser A, Glossmann H, Wilcox WR, Rimoin DL, Smith M, Kratz L, Kelley RI, Valle D. Mutations in the gene encoding 3 beta-hydroxysteroid-delta 8, delta 7-isomerase cause X-linked dominant Conradi-H&#x000fc;nermann syndrome. <span><span class="ref-journal">Nat Genet. </span>1999;<span class="ref-vol">22</span>:291–4.</span> [<a href="/pubmed/10391219" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10391219</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-dcdp.REF.conradi.1914.86">Conradi E. Vorzeitiges aufreten von knochen und eigenartigen verkalkungskernen bei chondrodystrophia fotalis hypoplastica histologische und rontgenuntersuchungen. <span><span class="ref-journal">Jb Kinderheilk. </span>1914;<span class="ref-vol">80</span>:86–97.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="x-dcdp.REF.crovato.1985.1064">Crovato F, Rebora A. Acute skin manifestations of Conradi-Hunermann syndrome in a male adult. <span><span class="ref-journal">Arch Dermatol. </span>1985;<span class="ref-vol">121</span>:1064–5.</span> [<a href="/pubmed/4026347" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4026347</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-dcdp.REF.de_raeve.1989.167">De Raeve L, Song M, De Dobbeleer G, Spehl M, Van Regemorter N. Lethal course of X-linked dominant chondrodysplasia punctata in a male newborn. <span><span class="ref-journal">Dermatologica. </span>1989;<span class="ref-vol">178</span>:167–70.</span> [<a href="/pubmed/2566519" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2566519</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-dcdp.REF.derry.1999.286">Derry JM, Gormally E, Means GD, Zhao W, Meindl A, Kelley RI, Boyd Y, Herman GE. Mutations in a delta 8-delta 7 sterol isomerase in the tattered mouse and X-linked dominant chondrodysplasia punctata. jderry@immunex.com. <span><span class="ref-journal">Nat Genet. </span>1999;<span class="ref-vol">22</span>:286–90.</span> [<a href="/pubmed/10391218" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10391218</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-dcdp.REF.furtado.2010.2838">Furtado LV, Bayrak-Toydemir P, Hulinsky B, Damjanovich K, Carey JC, Rope AF. A novel X-linked multiple congenital anomaly syndrome associated with an EBP mutation. <span><span class="ref-journal">Am J Med Genet A. </span>2010;<span class="ref-vol">152A</span>:2838–44.</span> [<a href="/pubmed/20949533" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20949533</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-dcdp.REF.grange.2000.328">Grange DK, Kratz LE, Braverman NE, Kelley RI. CHILD syndrome caused by deficiency of 3beta-hydroxysteroid-delta8, delta7-isomerase. <span><span class="ref-journal">Am J Med Genet. </span>2000;<span class="ref-vol">90</span>:328–35.</span> [<a href="/pubmed/10710233" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10710233</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-dcdp.REF.happle.1979.65">Happle R. X-linked dominant chondrodysplasia punctata: review of literature and report of a case. <span><span class="ref-journal">Hum Genet. </span>1979;<span class="ref-vol">53</span>:65–73.</span> [<a href="/pubmed/535904" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 535904</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-dcdp.REF.happle.1981.64">Happle R. Cataracts as a marker of genetic heterogeneity in chondrodysplasia punctata. <span><span class="ref-journal">Clin Genet. </span>1981;<span class="ref-vol">19</span>:64–6.</span> [<a href="/pubmed/7460383" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7460383</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-dcdp.REF.happle.2000.341">Happle R, K&#x000f6;nig A, Grzeschik KH. Behold the CHILD, it's only one: CHILD syndrome is not caused by deficiency of 3 beta-hydroxysteroid-Delta 8, Delta 7-isomerase. <span><span class="ref-journal">Am J Med Genet. </span>2000;<span class="ref-vol">94</span>:341–3.</span> [<a href="/pubmed/11038450" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11038450</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-dcdp.REF.has.2000.1951">Has C, Bruckner-Tuderman L, Muller D, Floeth M, Folkers E, Donnai D, Traupe H. The Conradi-Hunerman-Happle syndrome (CDPX2) and emopamil binding protein: novel mutations, and somatic and gonadal mosaicism. <span><span class="ref-journal">Hum Mol Genet. </span>2000;<span class="ref-vol">9</span>:1951–5.</span> [<a href="/pubmed/10942423" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10942423</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-dcdp.REF.herman.2000.357">Herman GE. X-linked dominant disorders of cholesterol biosynthesis in man and mouse. <span><span class="ref-journal">Biochim Biophys Acta. </span>2000;<span class="ref-vol">1529</span>:357–73.</span> [<a href="/pubmed/11111102" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11111102</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-dcdp.REF.herman.2002.434">Herman GE, Kelley RI, Pureza V, Smith D, Kopacz K, Pitt J, Sutphen R, Sheffield LJ, Metzenberg AB. Characterization of mutations in 22 females with X-linked dominant chondrodysplasia punctata (Happle syndrome). <span><span class="ref-journal">Genet Med. </span>2002;<span class="ref-vol">4</span>:434–8.</span> [<a href="/pubmed/12509714" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12509714</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-dcdp.REF.hochman.1987.565">Hochman M, Fee WE Jr. Conradi-Hunermann syndrome. Case report. <span><span class="ref-journal">Ann Otol Rhinol Laryngol. </span>1987;<span class="ref-vol">96</span>:565–8.</span> [<a href="/pubmed/3674654" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3674654</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-dcdp.REF.hoang.2004.53">Hoang MP, Carder KR, Pandya AG, Bennett MJ. Ichthyosis and keratotic follicular plugs containing dystrophic calcification in newborns: Distinctive histopathologic features of X-linked dominant chondrodysplasia punctata (Conradi-Hunermann-Happle syndrome). <span><span class="ref-journal">Am J Dermatopathol. </span>2004;<span class="ref-vol">26</span>:53–8.</span> [<a href="/pubmed/14726822" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14726822</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-dcdp.REF.h_nermann.1931.1">H&#x000fc;nermann C. Chondrodysplasia calcificans congeneita als abortive form der chondrodystrophia. <span><span class="ref-journal">Z Kindergeilkd. </span>1931;<span class="ref-vol">51</span>:1–19.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="x-dcdp.REF.ikegawa.2000.300">Ikegawa S, Ohashi H, Ogata T, Honda A, Tsukahara M, Kubo T, Kimizuka M, Shimode M, Hasegawa T, Nishimura G, Nakmura Y. Novel and recurrent EBP mutations in X-linked chondrodysplasia punctata. <span><span class="ref-journal">Am J Med Genet. </span>2000;<span class="ref-vol">94</span>:300–5.</span> [<a href="/pubmed/11038443" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11038443</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-dcdp.REF.kelley.1999.213">Kelley RI, Wilcox WG, Smith M, Kratz LE, Moser A, Rimoin DS. Abnormal sterol metabolism in patients with Conradi-Hunerman-Happle syndrome and sporadic lethal chondrodysplasia punctata. <span><span class="ref-journal">Am J Med Genet. </span>1999;<span class="ref-vol">83</span>:213–19.</span> [<a href="/pubmed/10096601" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10096601</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-dcdp.REF.kelley.2005.95">Kelley RI, Maegawa GH, Leite JC, Kratz L. The male with Conradi-Hunermann syndrome (CDPX2): A distinct phenotype. <span><span class="ref-journal">Proc Greenwood Genet Center. </span>2005;<span class="ref-vol">24</span>:95.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="x-dcdp.REF.k_nig.2000.339">K&#x000f6;nig A, Happle R, Bornholdt D, Engel H, Grzeschik KH. Mutations in the NSDHL gene, encoding a 3beta-hydroxysteroid dehydrogenase, cause CHILD syndrome. <span><span class="ref-journal">Am J Med Genet. </span>2000;<span class="ref-vol">90</span>:339–46.</span> [<a href="/pubmed/10710235" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10710235</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-dcdp.REF.mason.2002.1995">Mason DE, Sanders JO, MacKenzie WG, Nakata Y, Winter R. Spinal deformity in chondrodysplasia punctata. <span><span class="ref-journal">Spine. </span>2002;<span class="ref-vol">27</span>:1995–2002.</span> [<a href="/pubmed/12634559" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12634559</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-dcdp.REF.milunsky.2003.249">Milunsky JM, Maher TA, Metzenberg AB. Molecular, biochemical, and phenotypic analysis of a hemizygous male with a severe atypical phenotype for X-linked Dominant Conradi-Hunermann-Happle syndrome and a mutation in EBP. <span><span class="ref-journal">Am J Med Genet. </span>2003;<span class="ref-vol">116A</span>:249–54.</span> [<a href="/pubmed/12503101" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12503101</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-dcdp.REF.omobono.1993.117">Omobono E, Goetsch W. Chondrodysplasia punctata (the Conradi-Hunermann syndrome). A clinical case report and review of the literature. <span><span class="ref-journal">Minerva Pediatr. </span>1993;<span class="ref-vol">45</span>:117–21.</span> [<a href="/pubmed/8341225" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8341225</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-dcdp.REF.porter.2011.6">Porter FD, Herman GE. Malformation syndromes caused by disorders of cholesterol synthesis. <span><span class="ref-journal">J Lipid Res. </span>2011;<span class="ref-vol">52</span>:6–34.</span> [<a href="/pmc/articles/PMC2999931/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2999931</span></a>] [<a href="/pubmed/20929975" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20929975</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-dcdp.REF.sheffield.2001.283">Sheffield LJ. Comment on Traupe&#x02019;s tribute to Rudolf Happle. <span><span class="ref-journal">Am J Med Genet. </span>2001;<span class="ref-vol">101</span>:283.</span> [<a href="/pubmed/11424147" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11424147</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-dcdp.REF.shirahama.2003.78">Shirahama S, Miyahara A, Kitoh H, Honda A, Kawase A, Yamada K, Mabuchi A, Kura H, Yokoyama Y, Tsutsumi M, Ikeda T, Tanaka N, Nishimura G, Ohashi H, Ikegawa S. Skewed X-chromosome inactivation causes intra-familial phenotypic variation of an EBP mutation in a family with X-linked dominant chondrodysplasia punctata. <span><span class="ref-journal">Hum Genet. </span>2003;<span class="ref-vol">112</span>:78–83.</span> [<a href="/pubmed/12483303" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12483303</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-dcdp.REF.sutphen.1995.489">Sutphen R, Amar MJ, Kousseff BG, Toomey KE. XXY male with X-linked dominant chondrodysplasia punctata (Happle syndrome). <span><span class="ref-journal">Am J Med Genet. </span>1995;<span class="ref-vol">57</span>:489–92.</span> [<a href="/pubmed/7677157" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7677157</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-dcdp.REF.tan.2010">Tan C, Haverfield E, Dempsey M, Kratz L, Descartes M, Powell B. X-linked dominant chondrodysplasia punctata and EBP mutations in males. Poster session. Albuquerque, NM: American College of Medical Genetics Annual Clinical Genetics Meeting; 2010.</div></li><li class="half_rhythm"><div class="bk_ref" id="x-dcdp.REF.traupe.1999.324">Traupe H. Functional X-chromosomal mosaicism of the skin: Rudolph Happle and the lines of Blaschko. <span><span class="ref-journal">Am J Med Genet. </span>1999;<span class="ref-vol">85</span>:324–9.</span> [<a href="/pubmed/10398252" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10398252</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="x-dcdp.REF.tronnier.1992.221">Tronnier M, Froster-Iskenius UG, Schmeller W, Happle R, Wolff HH. X-chromosome dominant chondrodysplasia punctata (Happle) in a boy. <span><span class="ref-journal">Hautarzt. </span>1992;<span class="ref-vol">43</span>:221–5.</span> [<a href="/pubmed/1597371" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1597371</span></a>]</div></li></ul></div></div><div id="x-dcdp.Chapter_Notes"><h2 id="_x-dcdp_Chapter_Notes_">Chapter Notes</h2><div id="x-dcdp.Author_Notes"><h3>Author Notes</h3><p><a href="http://dnatesting.uchicago.edu/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">dnatesting.uchicago.edu</a></p></div><div id="x-dcdp.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>31 May 2011 (me) Review posted live</div></li><li class="half_rhythm"><div>13 July 2009 (md) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK55062</span><span class="label">PMID: <a href="/pubmed/21634086" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">21634086</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cdp1-xlr/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/chac/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK55062&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK55062/?report=reader">PubReader</a></li><li><a href="/books/NBK55062/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK55062" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK55062" style="display:none" title="Cite this Page"><div class="bk_tt">Dempsey MA, Tan C, Herman GE. Chondrodysplasia Punctata 2, X-Linked. 2011 May 31. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK55062/pdf/Bookshelf_NBK55062.pdf">PDF version of this page</a> (585K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#x-dcdp.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#x-dcdp.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#x-dcdp.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#x-dcdp.Genetically_Related_Allelic_Disor" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#x-dcdp.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#x-dcdp.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#x-dcdp.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#x-dcdp.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#x-dcdp.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#x-dcdp.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#x-dcdp.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=10682[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">EBP</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=2476132" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=2476132" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=2476132" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=2476132" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25814754" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Emopamil binding protein mutation in conradi-hünermann-happle syndrome representing plaque-type psoriasis.</a><span class="source">[Indian J Dermatol. 2015]</span><div class="brieflinkpop offscreen_noflow">Emopamil binding protein mutation in conradi-hünermann-happle syndrome representing plaque-type psoriasis.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ozyurt K, Subasioglu A, Ozturk P, Inci R, Ozkan F, Bueno E, Cañueto J, González Sarmiento R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Indian J Dermatol. 2015 Mar-Apr; 60(2):216. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/10391218" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Mutations in a delta 8-delta 7 sterol isomerase in the tattered mouse and X-linked dominant chondrodysplasia punctata. jderry@immunex.com.</a><span class="source">[Nat Genet. 1999]</span><div class="brieflinkpop offscreen_noflow">Mutations in a delta 8-delta 7 sterol isomerase in the tattered mouse and X-linked dominant chondrodysplasia punctata. jderry@immunex.com.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Derry JM, Gormally E, Means GD, Zhao W, Meindl A, Kelley RI, Boyd Y, Herman GE. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Nat Genet. 1999 Jul; 22(3):286-90. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/12503101" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Molecular, biochemical, and phenotypic analysis of a hemizygous male with a severe atypical phenotype for X-linked dominant Conradi-Hunermann-Happle syndrome and a mutation in EBP.</a><span class="source">[Am J Med Genet A. 2003]</span><div class="brieflinkpop offscreen_noflow">Molecular, biochemical, and phenotypic analysis of a hemizygous male with a severe atypical phenotype for X-linked dominant Conradi-Hunermann-Happle syndrome and a mutation in EBP.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Milunsky JM, Maher TA, Metzenberg AB. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Med Genet A. 2003 Jan 30; 116A(3):249-54. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/11038443" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Novel and recurrent EBP mutations in X-linked dominant chondrodysplasia punctata.</a><span class="source">[Am J Med Genet. 2000]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Novel and recurrent EBP mutations in X-linked dominant chondrodysplasia punctata.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ikegawa S, Ohashi H, Ogata T, Honda A, Tsukahara M, Kubo T, Kimizuka M, Shimode M, Hasegawa T, Nishimura G, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Med Genet. 2000 Oct 2; 94(4):300-5. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301712" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Focal Dermal Hypoplasia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Focal Dermal Hypoplasia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bostwick B, Van den Veyver IB, Sutton VR. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=21634086" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=21634086" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04170239a66ee2ba25dd09">Chondrodysplasia Punctata 2, X-Linked - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Chondrodysplasia Punctata 2, X-Linked - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:12:18-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal105&amp;ncbi_phid=CE8C0EB0E0415DE100000000007D002E&amp;ncbi_session=CE8C0EB0E0417011_0125SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK55062%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK55062&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK55062/&amp;ncbi_pagename=Chondrodysplasia Punctata 2, X-Linked - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C0EB0E0417011_0125SID /projects/books/PBooks@5.22 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>